Germany & Roche

Germany: Home to Siemens — Siemens Healthineers; benefits from growth.

Roche: Major diagnostics provider; growth forecasts favorable.

Germany: Germany is receiving and treating a US citizen infected with Ebola and quarantining exposed individuals, playing a role in the international medical response.

Roche: Roche is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Germany: Germany is home to Merck Group, a top company in the epigenetics market, indicating its contribution to the global industry.

Roche: Roche Ltd. is recognized as a top company in the epigenetics market, indicating its significant role and potential to benefit from market expansion.

Germany: Germany is the home country of Boehringer Ingelheim, a key player in the antibody therapeutics market.

Roche: Roche is a key player in the antibody therapeutics market, benefiting from the projected market growth.

Germany: Germany's factory orders fell, indicating a weaker economic performance, while its 10-year Bund yield climbed.

Roche: Roche agreed to pay Nurix Therapeutics up to $2.3 billion for rights to an experimental blood-cancer drug.

Germany: Part of European market; home to Carl Zeiss and Leica.

Roche: Partnered with PathAI for AI-enabled companion diagnostics; key player in digital pathology.